Daniel Powell Dolan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel Powell Dolan has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
Scott J. Swanson
Brigham and Women's Hospital Boston Massachusetts USA
7 shared publicationsSuden Kucukak
Division of Thoracic and Cardiac Surgery, Department of Surgery, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA
7 shared publicationsAbby White
Division of Thoracic and Cardiac Surgery, Department of Surgery, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA
6 shared publicationsRaphael Bueno
Division of Thoracic Surgery Brigham and Women's Hospital Boston Massachusetts USA
6 shared publicationsEmanuele Mazzola
Dana‐Farber Cancer Institute Boston Massachusetts USA
5 shared publications- Daniel N. Lee
Division of Thoracic Surgery Brigham and Women's Hospital Boston Massachusetts USA
4 shared publications
Latest Publications
- 15 September 2025
- Published by Wiley in Journal of Surgical Oncology
- Vol. 132 (5) , 987-994
Delayed Esophagectomy After Chemoradiation Is Not Associated With Increased Mortality or Recurrence
Objective: To evaluate the impact of delayed esophagectomy on the overall survival of esophageal cancer patients undergoing esophagectomy after CROSS.Methods: A retrospective analysis was done of a prospective database of esophagectomy patients who underwent CROSS therapy and esophagectomy from May 2016 to January 2020. Preoperative characteristics, postoperative adverse events, recurrence rates, and survival rates were compared between patients who underwent surgery within 60 days of CROSS completion versus > 60 days.Results: In total, 197 patients were included; 137 underwent surgery within 60 days (standard group, SG) versus 60 at > 60 days (delayed group, DG). Median time to surgery was 43 versus 76 days for the SG and DG groups. Median follow‐up was 60 months. No differences were observed for gender, race, home state, Eastern Cooperative Oncology Group score, and tumor characteristics. DG patients were older; had higher Charlson Comorbidity Scores; and more history of myocardial infarction, stroke, and smoking, all p ≤ 0.05. DG had increased odds of major postoperative adverse events (odds ratio 2.26, 95% confidence interval 1.11–4.20). Overall survival and recurrence were similar.Conclusion: Following CROSS, a delay in esophagectomy beyond 60 days was not associated with worse recurrence or overall survival despite increased comorbidities and postoperative events.
- 15 September 2025
- Published by Wiley in Journal of Surgical Oncology
- Vol. 132 (5) , 987-994
Delayed Esophagectomy After Chemoradiation Is Not Associated With Increased Mortality or Recurrence
Objective: To evaluate the impact of delayed esophagectomy on the overall survival of esophageal cancer patients undergoing esophagectomy after CROSS.Methods: A retrospective analysis was done of a prospective database of esophagectomy patients who underwent CROSS therapy and esophagectomy from May 2016 to January 2020. Preoperative characteristics, postoperative adverse events, recurrence rates, and survival rates were compared between patients who underwent surgery within 60 days of CROSS completion versus > 60 days.Results: In total, 197 patients were included; 137 underwent surgery within 60 days (standard group, SG) versus 60 at > 60 days (delayed group, DG). Median time to surgery was 43 versus 76 days for the SG and DG groups. Median follow‐up was 60 months. No differences were observed for gender, race, home state, Eastern Cooperative Oncology Group score, and tumor characteristics. DG patients were older; had higher Charlson Comorbidity Scores; and more history of myocardial infarction, stroke, and smoking, all p ≤ 0.05. DG had increased odds of major postoperative adverse events (odds ratio 2.26, 95% confidence interval 1.11–4.20). Overall survival and recurrence were similar.Conclusion: Following CROSS, a delay in esophagectomy beyond 60 days was not associated with worse recurrence or overall survival despite increased comorbidities and postoperative events.
- 18 July 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 403
Correlations of kinematic data with robotic experience and duration of practice on complications and readmissions
Robotic surgery is increasingly prevalent in thoracic surgery. Studies of specific kinematic data on outcomes are missing. The object of this study was to examine correlations between years in practice, robotic experience, and kinematic (motion) data on complications and readmissions. Kinematic data from the first lymph node dissection of anatomic robotic lung resections were combined with data from a prospectively maintained single institution database. Kinematic data included arm movement speed, economy of motion, and camera movement. Lobectomies and segmentectomies were matched and propensity-score weighted with inverse-probability treatment weights. Pearson's correlations, between years in practice, robotic experience, and kinematic data; and logistic regression; between years in practice and robotic experience on complications and readmissions were done. Lobectomies, 42, and segmentectomies, 31, from 2022 to 2023 were included. After matching, lymph nodes sampled were greater with lobectomies than segmentectomies, but other data were well matched; nodes sampled with lobes 13.4 vs 7.6 with segments, p < 0.001. Years in practice and robotic experience were not correlated with complications or readmissions. Significant correlations were noted between kinematic data and robotic experience. Length of stay had a negative correlation with robotic experience, -0.16, p < 0.001. No odds ratios were significant. In this small series, decreased length of stay was correlated with increased robotic experience which was a stronger outcome determinant than practice years. The complications and readmissions were not correlated with either measure. Increasing robotic experience may help optimize patient care but additional data are needed to establish usefulness of specific kinematic data.
- 18 July 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 403
Correlations of kinematic data with robotic experience and duration of practice on complications and readmissions
Robotic surgery is increasingly prevalent in thoracic surgery. Studies of specific kinematic data on outcomes are missing. The object of this study was to examine correlations between years in practice, robotic experience, and kinematic (motion) data on complications and readmissions. Kinematic data from the first lymph node dissection of anatomic robotic lung resections were combined with data from a prospectively maintained single institution database. Kinematic data included arm movement speed, economy of motion, and camera movement. Lobectomies and segmentectomies were matched and propensity-score weighted with inverse-probability treatment weights. Pearson's correlations, between years in practice, robotic experience, and kinematic data; and logistic regression; between years in practice and robotic experience on complications and readmissions were done. Lobectomies, 42, and segmentectomies, 31, from 2022 to 2023 were included. After matching, lymph nodes sampled were greater with lobectomies than segmentectomies, but other data were well matched; nodes sampled with lobes 13.4 vs 7.6 with segments, p < 0.001. Years in practice and robotic experience were not correlated with complications or readmissions. Significant correlations were noted between kinematic data and robotic experience. Length of stay had a negative correlation with robotic experience, -0.16, p < 0.001. No odds ratios were significant. In this small series, decreased length of stay was correlated with increased robotic experience which was a stronger outcome determinant than practice years. The complications and readmissions were not correlated with either measure. Increasing robotic experience may help optimize patient care but additional data are needed to establish usefulness of specific kinematic data.
- 19 January 2024
- Published by Elsevier in Journal of Surgical Research
- Vol. 296, 93-97
Chemical Localization With Robotic Bronchoscopy: Can It Aid Resection of Subsolid Lung Nodules?
- 19 January 2024
- Published by Elsevier in Journal of Surgical Research
- Vol. 296, 93-97
Chemical Localization With Robotic Bronchoscopy: Can It Aid Resection of Subsolid Lung Nodules?
- 14 August 2023
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 117 (2) , 297-303
Rapid Discharge After Anatomic Lung Resection: Is Ambulatory Surgery for Early Lung Cancer Possible?
- 14 August 2023
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 117 (2) , 297-303
Rapid Discharge After Anatomic Lung Resection: Is Ambulatory Surgery for Early Lung Cancer Possible?
- 9 May 2023
- Published by SAGE Publications in Foregut: The Journal of the American Foregut Society
- Vol. 3 (4) , 454-461
Delayed Esophagectomy is Associated With Inferior Survival: A National Cancer Database Study
Background: Locoregionally advanced esophageal cancer is typically treated with neoadjuvant chemoradiation followed by surgery 4 to 8 weeks later. Occasionally surgery is delayed >12 weeks; outcomes of this approach are not well studied. We hypothesized that delayed esophagectomy after chemoradiation would have inferior long-term overall survival relative to planned trimodality esophagectomy. Methods: Adult patients with locally advanced esophageal cancer (T 2−4a N 0 M 0 , T 0−4a N + M 0 ) who received multi-agent chemotherapy, radiation, and esophagectomy were identified in the 2018 National Cancer Database. Esophagectomy performed within 90 days from end of chemoradiation were categorized as “trimodality” and those ≥90 days were categorized as “delayed.” Primary outcome was overall survival measured using Kaplan-Meier estimates and Cox proportional hazard models. Secondary outcomes included surgical margin status, hospital length of stay, and readmission. Results: Included were 19 698 patients, 3905 (19.8%) “delayed.” Median time to surgery for trimodality patients was 51 days (IQR 41-63) versus 110 days (IQR 98-131) for delayed patients. Delayed patients tended to be older, non-white, have non-private insurance, and have more comorbidities. Overall survival was shorter for delayed patients (34.8 months) versus trimodality patients (43.1 months, P ≤ .001). In multivariable analysis, delay was associated with inferior overall survival (HR 1.15, 95% CI 1.08-1.23). Length of stay and readmission rate were similar between cohorts, but delay was associated with a higher rate of positive surgical margins (6.7% vs 4.6%, P ≤ .001). Conclusions: In the National Cancer Database, delayed esophagectomy is associated with inferior long-term survival. Nonetheless, delayed esophagectomy may be appropriate for select patients; further research is needed to identify the optimal approach.
- 9 May 2023
- Published by SAGE Publications in Foregut: The Journal of the American Foregut Society
- Vol. 3 (4) , 454-461
Delayed Esophagectomy is Associated With Inferior Survival: A National Cancer Database Study
Background: Locoregionally advanced esophageal cancer is typically treated with neoadjuvant chemoradiation followed by surgery 4 to 8 weeks later. Occasionally surgery is delayed >12 weeks; outcomes of this approach are not well studied. We hypothesized that delayed esophagectomy after chemoradiation would have inferior long-term overall survival relative to planned trimodality esophagectomy. Methods: Adult patients with locally advanced esophageal cancer (T 2−4a N 0 M 0 , T 0−4a N + M 0 ) who received multi-agent chemotherapy, radiation, and esophagectomy were identified in the 2018 National Cancer Database. Esophagectomy performed within 90 days from end of chemoradiation were categorized as “trimodality” and those ≥90 days were categorized as “delayed.” Primary outcome was overall survival measured using Kaplan-Meier estimates and Cox proportional hazard models. Secondary outcomes included surgical margin status, hospital length of stay, and readmission. Results: Included were 19 698 patients, 3905 (19.8%) “delayed.” Median time to surgery for trimodality patients was 51 days (IQR 41-63) versus 110 days (IQR 98-131) for delayed patients. Delayed patients tended to be older, non-white, have non-private insurance, and have more comorbidities. Overall survival was shorter for delayed patients (34.8 months) versus trimodality patients (43.1 months, P ≤ .001). In multivariable analysis, delay was associated with inferior overall survival (HR 1.15, 95% CI 1.08-1.23). Length of stay and readmission rate were similar between cohorts, but delay was associated with a higher rate of positive surgical margins (6.7% vs 4.6%, P ≤ .001). Conclusions: In the National Cancer Database, delayed esophagectomy is associated with inferior long-term survival. Nonetheless, delayed esophagectomy may be appropriate for select patients; further research is needed to identify the optimal approach.
- Open Access
- 1 August 2022
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 14 (8) , 2874-2879
Report on lung cancer surgery during COVID-19 pandemic at a high volume US institution
Original Article Report on lung cancer surgery during COVID-19 pandemic at a high volume US institution Daniel P. Dolan, Daniel N. Lee, Emily Polhemus, Suden Kucukak, Luis E. De León, Daniel Wiener, Michael T. Jaklitsch, Scott J. Swanson, Abby White
- 1 August 2022
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 14 (8) , 2874-2879
Open AccessReport on lung cancer surgery during COVID-19 pandemic at a high volume US institution
Original Article Report on lung cancer surgery during COVID-19 pandemic at a high volume US institution Daniel P. Dolan, Daniel N. Lee, Emily Polhemus, Suden Kucukak, Luis E. De León, Daniel Wiener, Michael T. Jaklitsch, Scott J. Swanson, Abby White
- 23 May 2022
- Published by Wiley in Journal of Surgical Oncology
- Vol. 126 (4) , 814-822
Salvage surgery for local recurrence after sublobar surgery in Stages I and II non‐small cell lung cancer
Background and Objectives: To examine if patients undergoing salvage surgery for local recurrence following sublobar resection (SLR) have similar perioperative complications and overall survival (OS) compared to lobectomy patients for early stage non‐small cell lung cancer (NSCLC).Methods: Patients undergoing lobectomy and SLR (segmentectomy or wedge resection) for Stages I and II NSCLC from 2010 to 2016 were reviewed. Lobectomy patients and those who underwent salvage surgery for local recurrence after SLR were compared. Salvage surgeries were curative‐intent resections for recurrence.Results: Cases included 634 lobectomies and 986 SLR. Fifty‐nine SLR patients (6.0%) recurred at a local site compared to 11 lobectomy patients (1.7%; p < 0.001). Twenty‐three locally recurrent SLR patients (39.0%) went on to salvage surgery. Peri‐operative complications after salvage surgeries were similar to lobectomies (34.8% 8/23 vs. 34.7% 220/634, p = 1.00). OS at 5 years for salvage surgery patients was similar to lobectomy patients (79.6% 13/23 vs. 70.6% 227/634, p = 0.23). OS for patients who underwent salvage surgery was significantly better than those who did not have salvage surgery for recurrence (79.6% vs. 53.0%, p = 0.02).Conclusions: Patients who undergo salvage surgery for local recurrence after SLR had similar perioperative complications and OS compared to lobectomy patients but less than half underwent salvage surgery.
- 23 May 2022
- Published by Wiley in Journal of Surgical Oncology
- Vol. 126 (4) , 814-822
Salvage surgery for local recurrence after sublobar surgery in Stages I and II non‐small cell lung cancer
Background and Objectives: To examine if patients undergoing salvage surgery for local recurrence following sublobar resection (SLR) have similar perioperative complications and overall survival (OS) compared to lobectomy patients for early stage non‐small cell lung cancer (NSCLC).Methods: Patients undergoing lobectomy and SLR (segmentectomy or wedge resection) for Stages I and II NSCLC from 2010 to 2016 were reviewed. Lobectomy patients and those who underwent salvage surgery for local recurrence after SLR were compared. Salvage surgeries were curative‐intent resections for recurrence.Results: Cases included 634 lobectomies and 986 SLR. Fifty‐nine SLR patients (6.0%) recurred at a local site compared to 11 lobectomy patients (1.7%; p < 0.001). Twenty‐three locally recurrent SLR patients (39.0%) went on to salvage surgery. Peri‐operative complications after salvage surgeries were similar to lobectomies (34.8% 8/23 vs. 34.7% 220/634, p = 1.00). OS at 5 years for salvage surgery patients was similar to lobectomy patients (79.6% 13/23 vs. 70.6% 227/634, p = 0.23). OS for patients who underwent salvage surgery was significantly better than those who did not have salvage surgery for recurrence (79.6% vs. 53.0%, p = 0.02).Conclusions: Patients who undergo salvage surgery for local recurrence after SLR had similar perioperative complications and OS compared to lobectomy patients but less than half underwent salvage surgery.
- Open Access
- 2 April 2022
- Published by Elsevier in JTCVS Techniques
- Vol. 14, 130-135
How I do it: Multiport video-assisted thoracoscopic surgery of the right middle lobe for non–small cell lung cancer: Right middle lobectomy in 12 steps
- 2 April 2022
- Published by Elsevier in JTCVS Techniques
- Vol. 14, 130-135
Open AccessHow I do it: Multiport video-assisted thoracoscopic surgery of the right middle lobe for non–small cell lung cancer: Right middle lobectomy in 12 steps
- 1 January 2022
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 34 (4) , 1340-1350
Short and Long-term Outcomes Among High-Volume vs Low-Volume Esophagectomy Surgeons at a High-Volume Center
- 1 January 2022
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 34 (4) , 1340-1350
Short and Long-term Outcomes Among High-Volume vs Low-Volume Esophagectomy Surgeons at a High-Volume Center